Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an announcement.
On April 30, 2025, MIRA Pharmaceuticals, Inc. announced its acquisition of SKNY Pharmaceuticals, Inc., a biotechnology company specializing in obesity and nicotine dependence therapies. This strategic move, valued at over $60 million, aims to enhance MIRA’s market position by integrating complementary assets and expanding its pipeline, ultimately strengthening shareholder value.
More about MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates in the biotechnology industry, focusing on developing therapies for various health conditions.
Average Trading Volume: 1,170,223
Technical Sentiment Signal: Hold
See more data about MIRA stock on TipRanks’ Stock Analysis page.